Head-to-head dispatch
Lttl vs ShedRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Lttl (pronounced “little”) publishes its entire term ladder on one public page — every medication, route and commitment length, month-to-month rung included — alongside compounded semaglutide and tirzepatide, a low-dose microdose line and a longevity range.
Marked down on: One advertised figure is purchasable at no tier: every product card prints the same “from $129/mo”, including tirzepatide, whose own four rungs are $279, $249, $229 and $199
Desk Score
Widest formulation spread in the ranking — injection, liquid drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
Marked down on: The advertised "as low as $239" tirzepatide rate needs a twelve-month commitment — month-to-month is $299
ShedRx takes this head-to-head with the higher Desk Score, 85/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Lttl
66/100
C
ShedRx
85/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Lttl | ShedRx |
|---|---|---|
| Semaglutide | $199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay) | $199/mo |
| Tirzepatide | $279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay) | $299/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines. | People who want a needle-free route or a brand-name option without leaving one provider. |
| Desk Score | 66/100C | 85/100B |
The verdict
Desk pick — ShedRxShedRx takes this head-to-head with the higher Desk Score, 85/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.
Choose Lttl if…
Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.
$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay) sema · $279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay) tirz · Coverage not published
Choose ShedRx if…
People who want a needle-free route or a brand-name option without leaving one provider.
$199/mo sema · $299/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Lttl · ShedRx.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Lttl vs CoreAge Rx
- ShedRx vs Vaylen
- Lttl vs Strut Health
- ShedRx vs Ondra Health
- Lttl vs Invigor Medical
- ShedRx vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.